Analysis of IL-17+ cells in facet joints of patients with spondyloarthritis suggests that the innate immune pathway might be of greater relevance than the Th17-mediated adaptive immune response

Arthritis Research and Therapy

Volumn 13, Issue 3, 2011, Pages

  Appel, Heiner ^a   Maier, René ^a   Wu, Peihua ^a,b   Scheer, Rebecca ^a   Hempfing, Axel ^c   Kayser, Ralph ^a   Thiel, Andreas ^b   Radbruch, Andreas ^b   Loddenkemper, Christoph ^a   Sieper, Joachim ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b DEUTSCHES RHEUMA FORSCHUNGSZENTRUM   (Germany)

^c Werner Wicker Klinik   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; INTERLEUKIN 17; IONOMYCIN; MYELOPEROXIDASE; PHORBOL 13 ACETATE 12 MYRISTATE; STAPHYLOCOCCUS ENTEROTOXIN B; CCR6 PROTEIN, HUMAN; CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR6; IL17A PROTEIN, HUMAN;

ADAPTIVE IMMUNITY; ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; BLOOD; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; INNATE IMMUNITY; JOINT; MALE; MAST CELL; MONONUCLEAR CELL; NEUTROPHIL; OSTEOARTHRITIS; RHEUMATOID ARTHRITIS; SECRETORY CELL; SYNOVIAL FLUID; TH17 CELL; AGED; ANTIBODY SPECIFICITY; IMMUNOLOGY; LUMBAR VERTEBRA; METABOLISM; MIDDLE AGED; PATHOLOGY; SECRETION; ZYGAPOPHYSEAL JOINT;

ADAPTIVE IMMUNITY; ADULT; AGED; ANTIBODY SPECIFICITY; ANTIGENS, CD4; HUMANS; INTERLEUKIN-17; LUMBAR VERTEBRAE; MIDDLE AGED; OSTEOARTHRITIS; RECEPTORS, CCR6; SPONDYLITIS, ANKYLOSING; SYNOVIAL FLUID; TH17 CELLS; YOUNG ADULT; ZYGAPOPHYSEAL JOINT;

EID: 79959207913     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3370     Document Type: Article

References (35)

1. Braun J, Sieper J. Ankylosing spondylitis. Lancet 2007, 369:1379-1390. 10.1016/S0140-6736(07)60635-7, 17448825.
2. Boyle LH, Goodall JC, Opat SS, Gaston JS. The recognition of HLA-B27 by human CD4+ T lymphocytes. J Immunol 2001, 167:2619-2624.
3. Atagunduz P, Appel H, Kuon W, Wu P, Thiel A, Kloetzel PM, Sieper J. HLA-B27-restricted CD8+ T cell response to cartilage-derived self peptides in ankylosing spondylitis. Arthritis Rheum 2005, 52:892-901. 10.1002/art.20948, 15751060.
4. Baeten D, Kruithof E, Van den Bosch F, Demetter P, Van Damme N, Cuvelier C, De Vos M, Mielants H, Veys EM, De Keyser F. Immunomodulatory effects of anti-tumor necrosis factor α therapy on synovium in spondylarthropathy: histologic findings in eight patients from an open-label pilot study. Arthritis Rheum 2001, 44:186-195. 10.1002/1529-0131(200101)44:1<186::AID-ANR25>3.0.CO;2-B, 11212159.
5. Appel H, Kuhne M, Spiekermann S, Ebhardt H, Groszdanovic Z, Köhler D, Dreimann M, Hempfing A, Rudwaleit M, Stein H, Metz-Stavenhagen P, Sieper J, Loddenkemper C. Immunohistological analysis of zygapophyseal joints in patients with ankylosing spondylitis. Arthritis Rheum 2006, 54:2845-2851. 10.1002/art.22060, 16947385.
6. Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, Weaver CT. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005, 6:1123-1132. 10.1038/ni1254, 16200070.
7. Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH, Wang Y, Hood L, Zhu Z, Tian Q, Dong C. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005, 6:1133-1141. 10.1038/ni1261, 1618871, 16200068.
8. Chabaud M, Durand JM, Buchs N, Fossiez F, Page G, Frappart L, Miossec P. Human interleukin-17: a T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum 1999, 42:963-970. 10.1002/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E, 10323452.
9. Kebir H, Kreymborg K, Ifergan I, Dodelet-Devillers A, Cayrol R, Bernard M, Giuliani F, Arbour N, Becher B, Prat A. Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat Med 2007, 13:1173-1175. 10.1038/nm1651, 17828272.
10. Jandus C, Bioley G, Rivals JP, Dudler J, Speiser D, Romero P. Increased numbers of circulating polyfunctional Th17 memory cells in patients with seronegative spondylarthritides. Arthritis Rheum 2008, 58:2307-2317. 10.1002/art.23655, 18668556.
11. Shen H, Goodall JC, Hill Gaston JS. Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis. Arthritis Rheum 2009, 60:1647-1656. 10.1002/art.24568, 19479869.
12. Vandooren B, Noordenbos T, Ambarus C, Krausz S, Cantaert T, Yeremenko N, Boumans M, Lutter R, Tak PP, Baeten D. Absence of a classically activated macrophage cytokine signature in peripheral spondylarthritis, including psoriatic arthritis. Arthritis Rheum 2009, 60:966-975. 10.1002/art.24406, 19333931.
13. Wendling D, Cedoz JP, Racadot E, Dumoulin G. Serum IL-17, BMP-7, and bone turnover markers in patients with ankylosing spondylitis. Joint Bone Spine 2007, 74:304-305. 10.1016/j.jbspin.2006.11.005, 17369068.
14. Rudwaleit M, van der Heijde D, Landewé R, Akkoc N, Brandt J, Chou CT, Dougados M, Huang F, Gu J, Kirazli Y, Van den Bosch F, Olivieri I, Roussou E, Scarpato S, Sørensen IJ, Valle-Oñate R, Weber U, Wei J, Sieper J. The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis 2011, 70:25-31. 10.1136/ard.2010.133645, 21109520.
15. van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum 1984, 27:361-368. 10.1002/art.1780270401, 6231933.
16. Dougados M, van der Linden S, Juhlin R, Huitfeldt B, Amor B, Calin A, Cats A, Dijkmans B, Olivieri I, Pasero G, Veys E, Zeidler H, . the European Spondylarthropathy Study Group The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 1991, 34:1218-1227. 10.1002/art.1780341003, 1930310, the European Spondylarthropathy Study Group.
17. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JG, Wilder RL, Hunder GG. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31:315-324. 10.1002/art.1780310302, 3358796.
18. Resnick D, Niwayama G. Radiographic and pathologic features of spinal involvement in diffuse idiopathic skeletal hyperostosis (DISH). Radiology 1976, 119:559-568.
19. Thiel A, Radbruch A. Antigen-specific cytometry. Arthritis Res 1999, 1:25-29. 10.1186/ar7, 128866, 11094410.
20. Hueber AJ, Asquith DL, Miller AM, Reilly J, Kerr S, Leipe J, Melendez AJ, McInnes IB. Mast cells express IL-17A in rheumatoid arthritis synovium. J Immunol 2010, 184:3336-3340. 10.4049/jimmunol.0903566, 20200272.
21. Yeremenko N, Gofita I, Noordenbos T, Tak PP, Canete J, Baeten D. IL-17A producing cells as a therapeutic target in spondyloarthritis. J Transl Med 2010, 8(Suppl 1):>P42. 3024250, 21194459.
22. , Burton PR, Clayton DG, Cardon LR, Craddock N, Deloukas P, Duncanson A, Kwiatkowski DP, McCarthy MI, Ouwehand WH, Samani NJ, Todd JA, Donnelly P, Barrett JC, Davison D, Easton D, Evans DM, Leung HT, Marchini JL, Morris AP, Spencer CC, Tobin MD, Attwood AP, Boorman JP, Cant B, Everson U, Hussey JM, Jolley JD, Knight AS, Koch K, Meech E, et al. Wellcome Trust Case Control Consortium, Australo-Anglo-American Spondylitis Consortium (TASC) Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet 2007, 39:1329-1337. 10.1038/ng.2007.17, 2680141, 17952073, Wellcome Trust Case Control Consortium, Australo-Anglo-American Spondylitis Consortium (TASC).
23. DeLay ML, Turner MJ, Klenk EI, Smith JA, Sowders DP, Colbert RA. HLA-B27 misfolding and the unfolded protein response augment interleukin-23 production and are associated with Th17 activation in transgenic rats. Arthritis Rheum 2009, 60:2633-2643. 10.1002/art.24763, 2893331, 19714651.
24. Res PC, Piskin G, de Boer OJ, van der Loos CM, Teeling P, Bos JD, Teunissen MB. Overrepresentation of IL-17A and IL-22 producing CD8 T cells in lesional skin suggests their involvement in the pathogenesis of psoriasis. PLoS One 2010, 5:e14108. 10.1371/journal.pone.0014108, 2991333, 21124836.
25. Kobayashi T, Okamoto S, Hisamatsu T, Kamada N, Chinen H, Saito R, Kitazume MT, Nakazawa A, Sugita A, Koganei K, Isobe K, Hibi T. IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease. Gut 2008, 57:1682-1689. 10.1136/gut.2007.135053, 18653729.
26. Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 cells. Annu Rev Immunol 2009, 27:485-517. 10.1146/annurev.immunol.021908.132710, 19132915.
27. Huang W, La Russa V, Alzoubi A, Schwarzenberger P. Interleukin-17A: a T-cell-derived growth factor for murine and human mesenchymal stem cells. Stem Cells 2006, 24:1512-1518. 10.1634/stemcells.2005-0156, 16513762.
28. Ferretti S, Bonneau O, Dubois GR, Jones CE, Trifilieff A. IL-17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide-induced airway neutrophilia: IL-15 as a possible trigger. J Immunol 2003, 170:2106-2112.
29. Weaver CT, Hatton RD, Mangan PR, Harrington LE. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 2007, 25:821-852. 10.1146/annurev.immunol.25.022106.141557, 17201677.
30. Li L, Huang L, Vergis AL, Ye H, Bajwa A, Narayan V, Strieter RM, Rosin DL, Okusa MD. IL-17 produced by neutrophils regulates IFN-γ-mediated neutrophil migration in mouse kidney ischemia-reperfusion injury. J Clin Invest 2010, 120:331-342. 10.1172/JCI38702, 2798679, 20038794.
31. Malech HL, Nauseef WM. Primary inherited defects in neutrophil function: etiology and treatment. Semin Hematol 1997, 34:279-290.
32. Miossec P. Diseases that may benefit from manipulating the Th17 pathway. Eur J Immunol 2009, 39:667-669. 10.1002/eji.200839088, 19283719.
33. Hueber W, Patel DD, Dryja T, Wright AM, Koroleva I, Bruin G, Antoni C, Draelos Z, Gold MH, Durez P, Tak PP, Gomez-Reino JJ, Foster CS, Kim RY, Samson CM, Falk NS, Chu DS, Callanan D, Nguyen QD, Rose K, Haider A, Di Padova F. Psoriasis Study Group, Rheumatoid Arthritis Study Group, Uveitis Study Group Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis. Sci Transl Med 2010, 2:52ra72. Psoriasis Study Group, Rheumatoid Arthritis Study Group, Uveitis Study Group.
34. Baeten D, Sieper J, Emery P, Braun J, van der Heijde D, McInnes I, van Laar JM, Landewé R, Wordsworth P, Wollenhaupt J, Kellner H, Paramarta J, Bertolino AP, Wright AM, Hueber W. The anti-IL7A monoclonal antibody secukinumab (AIN457) showed good safety and efficacy in the treatment of active ankylosing spondylitis. Arthritis Rheum 2010, 62:2840-2841.
35. Zou J, Rudwaleit M, Brandt J, Thiel A, Braun J, Sieper J. Up regulation of the production of tumour necrosis factor α and interferon γ by T cells in ankylosing spondylitis during treatment with etanercept. Ann Rheum Dis 2003, 62:561-564. 10.1136/ard.62.6.561, 1754568, 12759295.